Introduction to Using Clinically Validated Variants In Assessing Ngs Technologies
Let's dive into the details surrounding Using Clinically Validated Variants In Assessing Ngs Technologies. Eunice Lee, Ph.D., Branch Chief, Division of Molecular Genetics and Pathology, OIR/CDRH/FDA.
Using Clinically Validated Variants In Assessing Ngs Technologies Comprehensive Overview
You Li, Ph.D., Reviewer, Division of Molecular Genetics and Pathology, OIR/CDRH/FDA. In this webcast, Gabe Rudy, Vice President of Product Development, will showcase publicly available databases and resources ... Download the free Sanger sequencing handbook at http://www.thermofisher.com/sangerhandbook To learn more about the
The Green Park Collaborative (GPC) hosted a webinar on the College of American Pathologists' (CAP) Accreditation Program for ...
Summary & Highlights for Using Clinically Validated Variants In Assessing Ngs Technologies
- NGS
- Speaker: Dr. Florian Battke | CeGaT Management Presented at: Tricon 2022.
- Albert Ferran finished his MSc in Genetic Anthropology in 2011 and worked as a research scientist at The University of Barcelona ...
- Next generation sequencing
- The
That wraps up our extensive overview of Using Clinically Validated Variants In Assessing Ngs Technologies.
